Syndrome de détresse respiratoire de l'adulte : Questions médicales fréquentes
Nom anglais: Respiratory Distress Syndrome
Descriptor UI:D012128
Tree Number:C08.618.840
Termes MeSH sélectionnés :
Routinely Collected Health Data
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de détresse respiratoire de l'adulte : Questions médicales les plus fréquentes",
"headline": "Syndrome de détresse respiratoire de l'adulte : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de détresse respiratoire de l'adulte : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de détresse respiratoire de l'adulte"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles respiratoires",
"url": "https://questionsmedicales.fr/mesh/D012120",
"about": {
"@type": "MedicalCondition",
"name": "Troubles respiratoires",
"code": {
"@type": "MedicalCode",
"code": "D012120",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C08.618"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de détresse respiratoire de l'adulte",
"alternateName": "Respiratory Distress Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D012128",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Lorraine B Ware",
"url": "https://questionsmedicales.fr/author/Lorraine%20B%20Ware",
"affiliation": {
"@type": "Organization",
"name": "Departments of Medicine and Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA."
}
},
{
"@type": "Person",
"name": "Tariq Cheema",
"url": "https://questionsmedicales.fr/author/Tariq%20Cheema",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Carolyn S Calfee",
"url": "https://questionsmedicales.fr/author/Carolyn%20S%20Calfee",
"affiliation": {
"@type": "Organization",
"name": "Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA."
}
},
{
"@type": "Person",
"name": "Michael A Matthay",
"url": "https://questionsmedicales.fr/author/Michael%20A%20Matthay",
"affiliation": {
"@type": "Organization",
"name": "Departments of Medicine and Anesthesia, University of California San Francisco, San Francisco, CA, USA."
}
},
{
"@type": "Person",
"name": "Nuala J Meyer",
"url": "https://questionsmedicales.fr/author/Nuala%20J%20Meyer",
"affiliation": {
"@type": "Organization",
"name": "Pulmonary, Allergy and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Electronic address: nuala.meyer@pennmedicine.upenn.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected data.",
"datePublished": "2023-03-16",
"url": "https://questionsmedicales.fr/article/36933612",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cct.2023.107162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dementia prevalence estimation among the main ethnic groups in New Zealand: a population-based descriptive study of routinely collected health data.",
"datePublished": "2022-09-07",
"url": "https://questionsmedicales.fr/article/36691174",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-062304"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimating the hospital costs of care for people living with HIV in England using routinely collected data.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37641541",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/hiv.13529"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identifying potential patients with diabetes-related dementia: a descriptive approach using routinely collected data.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37536311",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Staffing levels and hospital mortality in England: a national panel study using routinely collected data.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37197808",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjopen-2022-066702"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil respiratoire",
"item": "https://questionsmedicales.fr/mesh/D012140"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012120"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndrome de détresse respiratoire de l'adulte",
"item": "https://questionsmedicales.fr/mesh/D012128"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de détresse respiratoire de l'adulte - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de détresse respiratoire de l'adulte",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de détresse respiratoire de l'adulte",
"description": "Comment diagnostique-t-on le SDRA ?\nQuels examens sont utilisés pour le SDRA ?\nQuels critères sont utilisés pour le SDRA ?\nLe SDRA peut-il être confondu avec d'autres maladies ?\nQuels signes cliniques indiquent le SDRA ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de détresse respiratoire de l'adulte",
"description": "Quels sont les symptômes du SDRA ?\nLe SDRA provoque-t-il de la toux ?\nComment se manifeste l'hypoxie dans le SDRA ?\nLe SDRA entraîne-t-il des douleurs thoraciques ?\nY a-t-il des signes d'anxiété avec le SDRA ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de détresse respiratoire de l'adulte",
"description": "Comment prévenir le SDRA ?\nLe sevrage tabagique aide-t-il à prévenir le SDRA ?\nLes vaccinations peuvent-elles prévenir le SDRA ?\nLe contrôle des maladies chroniques aide-t-il ?\nLes soins postopératoires peuvent-ils prévenir le SDRA ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de détresse respiratoire de l'adulte",
"description": "Quels traitements sont disponibles pour le SDRA ?\nLe SDRA nécessite-t-il une hospitalisation ?\nLes corticostéroïdes sont-ils utilisés pour le SDRA ?\nLa ventilation non invasive est-elle efficace pour le SDRA ?\nLe SDRA peut-il être traité par des médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de détresse respiratoire de l'adulte",
"description": "Quelles sont les complications du SDRA ?\nLe SDRA peut-il entraîner des séquelles ?\nLe SDRA augmente-t-il le risque de décès ?\nQuelles infections peuvent survenir avec le SDRA ?\nLe SDRA peut-il causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de détresse respiratoire de l'adulte",
"description": "Quels sont les facteurs de risque du SDRA ?\nL'âge influence-t-il le risque de SDRA ?\nLe tabagisme est-il un facteur de risque ?\nLes maladies pulmonaires chroniques augmentent-elles le risque ?\nLes interventions chirurgicales augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D012128?mesh_terms=Routinely+Collected+Health+Data&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le SDRA ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le SDRA est diagnostiqué par des examens cliniques, radiographies et tests de gaz du sang."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour le SDRA ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les radiographies thoraciques et les tomodensitométries sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le SDRA ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères de Berlin classifient le SDRA en léger, modéré et sévère selon l'hypoxie."
}
},
{
"@type": "Question",
"name": "Le SDRA peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des pneumonies ou des embolies pulmonaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent le SDRA ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une respiration rapide, une cyanose et une détresse respiratoire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du SDRA ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent une dyspnée, une tachypnée et une hypoxie sévère."
}
},
{
"@type": "Question",
"name": "Le SDRA provoque-t-il de la toux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une toux sèche peut être présente, mais elle n'est pas toujours significative."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'hypoxie dans le SDRA ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoxie se manifeste par une saturation en oxygène faible et une cyanose."
}
},
{
"@type": "Question",
"name": "Le SDRA entraîne-t-il des douleurs thoraciques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques peuvent survenir, mais elles ne sont pas toujours présentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'anxiété avec le SDRA ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété peut être présente en raison de la difficulté à respirer."
}
},
{
"@type": "Question",
"name": "Comment prévenir le SDRA ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la gestion des facteurs de risque et le traitement précoce des infections."
}
},
{
"@type": "Question",
"name": "Le sevrage tabagique aide-t-il à prévenir le SDRA ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, arrêter de fumer réduit le risque de complications pulmonaires, y compris le SDRA."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir le SDRA ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations contre la grippe et le pneumocoque peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Le contrôle des maladies chroniques aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle des maladies chroniques comme l'asthme peut aider à prévenir le SDRA."
}
},
{
"@type": "Question",
"name": "Les soins postopératoires peuvent-ils prévenir le SDRA ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins postopératoires appropriés peuvent réduire le risque de SDRA après une chirurgie."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le SDRA ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'oxygénothérapie, la ventilation mécanique et le traitement de la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Le SDRA nécessite-t-il une hospitalisation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des cas de SDRA nécessitent une hospitalisation en soins intensifs."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils utilisés pour le SDRA ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'inflammation dans certains cas de SDRA."
}
},
{
"@type": "Question",
"name": "La ventilation non invasive est-elle efficace pour le SDRA ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être efficace dans les cas légers, mais la ventilation invasive est souvent nécessaire."
}
},
{
"@type": "Question",
"name": "Le SDRA peut-il être traité par des médicaments ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être utilisés pour traiter la cause sous-jacente, mais pas le SDRA directement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du SDRA ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance respiratoire, les infections et les lésions pulmonaires."
}
},
{
"@type": "Question",
"name": "Le SDRA peut-il entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des séquelles pulmonaires peuvent persister après la guérison du SDRA."
}
},
{
"@type": "Question",
"name": "Le SDRA augmente-t-il le risque de décès ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SDRA a un taux de mortalité élevé, surtout dans les cas sévères."
}
},
{
"@type": "Question",
"name": "Quelles infections peuvent survenir avec le SDRA ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections pulmonaires, comme la pneumonie, sont fréquentes chez les patients atteints de SDRA."
}
},
{
"@type": "Question",
"name": "Le SDRA peut-il causer des problèmes cardiaques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le SDRA peut entraîner des complications cardiaques en raison de l'hypoxie prolongée."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du SDRA ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent les infections, les traumatismes, la pneumonie et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de SDRA ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru de développer un SDRA."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de complications pulmonaires et de SDRA."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires chroniques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la BPCO augmentent le risque de développer un SDRA."
}
},
{
"@type": "Question",
"name": "Les interventions chirurgicales augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interventions chirurgicales, surtout thoraciques, peuvent augmenter le risque de SDRA."
}
}
]
}
]
}
Routinely-collected healthcare systems data (HSD) are proposed to improve the efficiency of clinical trials. A comparison was undertaken between cardiovascular (CVS) data from a clinical trial databas...
Protocol-defined and clinically reviewed CVS events (heart failure (HF), acute coronary syndrome (ACS), thromboembolic stroke, venous and arterial thromboembolism) were identified within the trial dat...
From 1200 eligible participants, 71 protocol-defined clinically reviewed CVS events were recorded in the trial database. 45 resulted in a hospital admission and therefore could have been recorded by e...
Concordance between datasets was lower than anticipated and the HSD used could not straightforwardly replace current trial practices, nor directly identify protocol-defined CVS events. Further work is...
Estimates of dementia prevalence in New Zealand (NZ) have previously been extrapolated from limited Australasian studies, which may be neither accurate nor reflect NZ's unique population and diverse e...
A population-based descriptive study....
Seven national health data sets within the NZ Integrated Data Infrastructure (IDI) were linked. Diagnosed dementia prevalence for each year was calculated using the IDI age 60+ and age 80+ populations...
Diagnosed dementia individuals in the health datasets were identified by diagnostic or medication codes used in each of the data sets with deduplication of those who appeared in more than one data set...
The crude diagnosed dementia prevalence was 3.8%-4.0% in the age 60+ population and 13.7%-14.4% in the age 80+ population across the four study years. Dementia prevalence age-sex standardised to the I...
This study provides the best estimate to date for dementia prevalence in NZ but is limited to those people who were identified as having dementia based on data from the seven included data sets. The f...
Understanding the health care activity and associated hospital costs of caring for people living with HIV is an important component of assessing the cost effectiveness of new technologies and for budg...
Data collected between 2010 and 2017 from an English HIV treatment centre were combined with national reference costs to estimate the rate of hospital attendances and costs per quarter year, according...
People living with HIV experienced an unadjusted average of 0.028 (standard deviation [SD] 0.20) inpatient episodes per quarter, equivalent to one every 9 years, and 1.85 (SD 2.30) outpatient visits p...
A number of factors predicted hospital activity and costs, but CD4 cell count and new patient status were the strongest. The study results can be incorporated into future economic evaluations and budg...
Diabetes-related dementia (DRD) is a new dementia subtype associated with type 2 diabetes mellitus, first described in 2013. This study investigated data from a local New Zealand memory service to ide...
Using routinely collected data from 2013-2021, we selected a sample of people with dementia, diabetes, and no CT evidence of Alzheimer's disease (AD), vascular dementia, or frontotemporal dementia. We...
Forty (16%) of 249 patients with diabetes and dementia had "normal" CT scans (DRD subgroup), and 38 (15%) had AD (AD subgroup). Compared to NZ Europeans, disproportionally more Māori and Pacific Islan...
We have replicated the findings of the 2013 DRD research and have demonstrated a higher risk for the DRD subtype of dementia among the Māori and Pacific Islander patients in our sample....
Examine the association between multiple clinical staff levels and case-mix adjusted patient mortality in English hospitals. Most studies investigating the association between hospital staffing levels...
Retrospective observational study of routinely available data....
138 National Health Service hospital trusts that provided general acute adult services in England between 2015 and 2019....
Standardised mortality rates were derived from the Summary Hospital level Mortality Indicator data set, with observed deaths as outcome in our models and expected deaths as offset. Staffing levels wer...
Hospitals with lower levels of medical and allied healthcare professional (AHP) staff (e.g, occupational therapy, physiotherapy, radiography, speech and language therapy) had significantly higher mort...
In additional to medicine and nursing, AHP staffing levels may influence hospital mortality rates. Considering multiple staff groups simultaneously when examining the association between hospital mort...
NCT04374812....
Despite well-documented clinical benefits of longitudinal doctor-patient continuity in primary care, continuity rates have declined. Assessment by practices or health commissioners is rarely undertake...
Using the Usual Provider of Care (UPC) score this study set out to measure continuity across 126 practices in the mobile, multi-ethnic population of East London, comparing these scores with the Genera...
A retrospective, cross-sectional study in all 126 practices in three East London boroughs....
The study population included patients who consulted three or more times between January 2017 and December 2018. Anonymised demographic and consultation data from the electronic health record were lin...
The mean UPC score for all 126 practices was 0.52 (range 0.32 to 0.93). There was a strong correlation between practice UPC scores measured in the 2 years to December 2018 and responses to the 2019 GP...
It is possible to measure continuity across all practices in a local health economy. Regular review of practice continuity rates can be used to support efforts to increase continuity within practice t...
Defining the optimal moment to start renal replacement therapy (RRT) in acute kidney injury (AKI) remains challenging. Multiple randomized controlled trials (RCTs) addressed this question whilst using...
Patients in the ICU of Ghent University Hospital were included at the time they met KDIGO-AKI-stage ≥ 2. We applied inverse-probability-of-censoring-weighted Aalen-Johansen estimators to evaluate 30-d...
Out of 13,403 eligible patients (60.8 ± 16.8 years, SOFA 7.0 ± 4.1), 5622 (63.4 ± 15.3 years, SOFA 8.2 ± 4.2) met KDIGO-AKI-stage ≥ 2. The DTR that delayed RRT until potassium ≥ 7 mmol/l, persisting o...
Our causal analysis of RCD to compare RRT initiation at different thresholds of refractory low pH, high potassium, and persisting oliguria identified a DTR that resulted in a decrease in 30-day ICU mo...
The prevalence of coronary artery disease is increasing due to the aging population and increasing prevalence of cardiovascular risk factors. Non-acute chest pain often is the first symptom of stable ...
We used routinely collected health data from the STIZON data warehouse in the Netherlands between 2010 and 2016. Patients > 18 years, with no history of cardiovascular disease, seen by the general pra...
In total 9029 patients were included during the study period, resulting in an incidence of new non-acute chest pain of 1.01/1000 patient-years. 2166 (24%) patients were referred to the cardiologist. I...
After referral, both communication from cardiologists and registration of the final diagnosis by GPs were suboptimal. Both cardiologists and GPs should make adequate communication and registration a p...
Researchers are increasingly seeking to use routinely collected data to support clinical trials. This approach has the potential to transform the way clinical trials are conducted in the future. The a...
This three-step Delphi method consisted of two rounds of anonymous web-based surveys and a virtual consensus meeting. Stakeholders included trialists, data infrastructures, funders of trials, regulato...
In the first survey, 66 respondents yielded over 260 questions or challenges. These were thematically grouped and merged into a list of 40 unique questions. Eighty-eight stakeholders then ranked their...
This prioritised list of seven questions should inform the direction of future research in this area and should direct efforts to ensure that the benefits in major infrastructure for routinely collect...
There are increasing concerns about harms related to suboptimal antipsychotic use. Here we describe recent population-based trends in antipsychotic use and harms in Australia and identify population g...
Using population-based data from the Australian Pharmaceutical Benefits Scheme (2015-2020), poisoning calls to the New South Wales (NSW) Poisons Information Centre (2015-2020) and poisoning deaths in ...
Quetiapine and olanzapine had the highest prevalence of use between 2015 and 2020. Noteworthy trends included increases of 9.1% and 30.8% in quetiapine use and poisonings, while olanzapine use decreas...
Ongoing potentially suboptimal antipsychotic use and associated harms highlight the need to monitor such patterns of use, for example through prescription monitoring systems....
